» Articles » PMID: 20001802

Roles of LPA in Ovarian Cancer Development and Progression

Overview
Journal Future Oncol
Specialty Oncology
Date 2009 Dec 17
PMID 20001802
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Lysophosphatidic acid (LPA), a bioactive phospholipid, stimulates survival, proliferation, adhesion, migration and invasion of ovarian cancer cells through the activation of G-protein-coupled plasma membrane receptors. LPA and its receptors are aberrantly expressed in ovarian cancer, with high levels predominantly found in malignant ascites and in the plasma of ovarian cancer patients. LPA signals multiple intracellular pathways, such as Ras/MEKK1-MAPK and PI3K/Akt, to promote growth factors and protease expression, and induce angiogenesis and tumor cell invasion through the extracellular matrix and across the basement membrane. Only a small portion of this intricate lipid-signaling cascade has been characterized thus far. We believe that elucidation of this complex transduction network will provide further opportunities to understand the mechanism of ovarian carcinogenesis, invasion and metastasis.

Citing Articles

Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high-grade serous ovarian cancer cells.

Romito O, Lemettre A, Chantome A, Champion O, Couty N, Ouldamer L Mol Oncol. 2024; 18(8):1853-1865.

PMID: 38480668 PMC: 11306528. DOI: 10.1002/1878-0261.13631.


Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells.

Grunt T, Wagner R, Ries A, Berghoff A, Preusser M, Grusch M Int J Oncol. 2024; 64(3).

PMID: 38214315 PMC: 10807641. DOI: 10.3892/ijo.2024.5612.


Perturbing plasma membrane lipid: a new paradigm for tumor nanotherapeutics.

Fei W, Yan J, Wu X, Yang S, Zhang X, Wang R Theranostics. 2023; 13(8):2471-2491.

PMID: 37215569 PMC: 10196822. DOI: 10.7150/thno.82189.


Pharmacological Inhibition of Lipid Import and Transport Proteins in Ovarian Cancer.

Lemberger L, Wagner R, Heller G, Pils D, Grunt T Cancers (Basel). 2022; 14(23).

PMID: 36497485 PMC: 9737127. DOI: 10.3390/cancers14236004.


Lipidomic Analysis of Archival Pathology Specimens Identifies Altered Lipid Signatures in Ovarian Clear Cell Carcinoma.

Mir S, Wong S, Narasimhan K, Esther C, Ji S, Burla B Metabolites. 2021; 11(9).

PMID: 34564414 PMC: 8469522. DOI: 10.3390/metabo11090597.